These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8639468)

  • 1. An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays.
    Chapman JW; Mobbs BG; McCready DR; Lickley HL; Trudeau ME; Hanna W; Kahn HJ; Sawka CA; Fish EB; Pritchard KI
    J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):323-8. PubMed ID: 8639468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: an exploratory investigation.
    Coradini D; Biganzoli E; Boracchi P; Bombardieri E; Seregni E; De Palo G; Martelli G; Di Fronzo G
    Int J Cancer; 1998 Aug; 79(4):305-11. PubMed ID: 9699519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
    Ravdin PM; Green S; Dorr TM; McGuire WL; Fabian C; Pugh RP; Carter RD; Rivkin SE; Borst JR; Belt RJ
    J Clin Oncol; 1992 Aug; 10(8):1284-91. PubMed ID: 1634918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.
    Chapman JA; Nielsen TO; Ellis MJ; Bernard P; Chia S; Gelmon KA; Pritchard KI; Le Maitre A; Goss PE; Leung S; Shepherd LE; Bramwell VH
    Breast Cancer Res; 2013; 15(4):R71. PubMed ID: 23972025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
    Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB
    Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer.
    Thorpe SM; Christensen IJ; Rasmussen BB; Rose C
    Eur J Cancer; 1993; 29A(7):971-7. PubMed ID: 8499151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of estrogen and progesterone receptors in female breast cancer. A single center study.
    Mathiesen O; Bonderup O; Carl J; Panduro J; Pedersen KO
    Acta Oncol; 1991; 30(6):691-5. PubMed ID: 1958388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
    Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
    Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
    Kurozumi S; Matsumoto H; Hayashi Y; Tozuka K; Inoue K; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
    BMC Cancer; 2017 May; 17(1):354. PubMed ID: 28532429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients.
    Vollenweider-Zerargui L; Barrelet L; Wong Y; Lemarchand-Béraud T; Gómez F
    Cancer; 1986 Mar; 57(6):1171-80. PubMed ID: 3943040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
    Baker VA; Puddefoot JR; Marsigliante S; Barker S; Goode AW; Vinson GP
    Br J Cancer; 1992 Dec; 66(6):1083-7. PubMed ID: 1457348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
    Kunc M; Biernat W; Senkus-Konefka E
    Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
    Fernandez MD; Alaghband-Zadeh J; Burn JI
    Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on Hormone Receptors and Prognosis in Breast Cancer.
    Nomura Y; Miura S; Koyama H; Enomoto K; Kasumi F; Yamamoto H; Kimura M; Tominaga T; Iino H; Morimoto T
    Cancer; 1992 Jan; 69(1):153-64. PubMed ID: 1727658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.